ScholarIQanswers from OpenAlex

Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects

PaperCitations, authors & open-access status

Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects have?

ScholarIQcitation count

Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects has 306 citations in the OpenAlex counts ScholarIQ stores.

When was Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects published?

ScholarIQyear

Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects has 2006 year in the ScholarIQ index.

What is the open-access status of Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects?

ScholarIQoa status

Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects has closed oa status in the ScholarIQ index.

What is the DOI of Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects?

ScholarIQdoi

The DOI for Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects is on the source record.

What is the PMID of Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects?

ScholarIQpmid

The PMID for Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects is on the source record.

What is the OpenAlex record for Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects?

ScholarIQopenalex

The OpenAlex for Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial